APLS vs AWK · rev $781.4M vs P/E 22, rev $4.65B
Apellis Pharmaceuticals Inc (APLS) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
APLS currently screens at market cap $2.29B. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the APLS and AWK stock pages for the full models.
Not investment advice.